Abstract
Total knee replacement effectively relieves arthritis pain but improvement in physical function varies. A clearer understanding of the patient attributes associated with differing levels of functional gain after TKR is critical to surgical decision making. We reviewed 8050 primary, unilateral TKR patients enrolled in a prospective registry between 2000 and 2005 who had complete data. We evaluated associations between 12-month function (SF12/PCS) and preoperative gender, age, BMI, emotional health (MCS), knee diagnosis, quadriceps strength, and physical function (PCS). More than 98% of patients reported pain relief (KS pain score). At 12 months, mean PCS gain was 13.6 points, but the distribution was bimodal. The mean gain in PCS in the 63% of patients with greater improvement was 21 (SD = 7), and 4.1 (SD = 7) in the remaining 37%. Increased likelihood of poor functional gain was associated with older age, body mass index (BMI) over 40, lower MCS, and poor quadriceps strength. While two-thirds of patients reported functional gain well above national average at 12 months post-TKR, 37% reported limited functional improvement. Further understanding of the patient attributes associated with limited improvement will guide the design of innovative strategies to improve functional outcomes.
Level of Evidence: Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
Ayers DC, Franklin PD, Ploutz-Snyder R, Boisvert CB. Total knee replacement outcome and coexisting physical and emotional illness. Clin Orthop Relat Res. 2005;440:157–161.
Ayers DC, Franklin PD, Trief PM, Ploutz-Snyder R, Freund DA. Psychological attributes of preoperative total joint replacement patients: implications for optimal physical outcome. J Arthroplasty. 2004;19:125–130.
Brandt KD, Radin EL, Dieppe PA, van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis. 2006;65:1261–1264.
Centers for Disease Control and Prevention (CDC). Physical activity among adults with a disability–United States, 2005. MMWR Morb Mortal Wkly Rep. 2007;56:1021–1024.
Doherty M. Risk factors for progression of knee osteoarthritis. Lancet. 2001;358:775–776.
Escobar A, Quintana JM, Bilbao A, Arostequi I, Laguente I, Vidaurreta I. Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage. 2007;15:273–280.
Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty. J Bone Joint Surg Am. 2004;86:963–974.
Franklin PD, McLaughlin J, Boisvert CB, Li W, Ayers DC. Pilot study of methods to document quantity and variation of independent patient exercise and activity after total knee arthroplasty. J Arthroplasty. 2006;21:157–163.
Gapeyeva H, Buht N, Peterson K, Ereline J, Haviko T, Paasuke M. Quadriceps femoris muscle voluntary isometric force production and relaxation characteristics before and 6 months after unilateral total knee arthroplasty in women. Knee Surg Sports Traumatol Arthrosc. 2007;15:202–211.
Hawker G, Wright J, Coyte P, Paul J, Dittus R, Croxford R, Katz B, Bombardier C, Heck D, Freund D. Health-related quality of life after knee replacement: results of the Knee Replacement Patient Outcomes Research Team Study. J Bone Joint Surg Am. 1998; 80:163–173.
Hawker GA, Wright JG, Coyte PC, Williams JI, Harvey B, Glazier R, Badley EM, Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med. 2000; 342:1016–1022.
Heck DA, Robinson RL, Partridge CM, Lubitz RM, Freund DA. Patient outcomes after knee replacement. Clin Orthop Relat Res. 1998;356:1–18.
Jones CA, Beaupre LA, Johnston DW, Suarez-Almazor ME. Total joint arthroplasties: current concepts of patient outcomes after surgery. Clin Geriatr Med. 2005;21:527–541.
Jordan JM, Linder GF, Renner JB, Fryer JG. The impact of arthritis in rural populations. Arthritis Care Res. 1995;4:242–250.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.
McClung CD, Zahiri Higa CA, Amstutz JK, Amstutz HC, Schmalzried TP. Relationship between body mass index and activity in hip and knee arthroplasty patients. J Orthop Res. 2000;18:35–59.
Mizner RL, Petterson SC, Stevens JE, Axe MJ, Snyder-Mackler L. Preoperative quadriceps strength predicts functional ability one year after total knee arthroplasty. J Rheumatol. 2005;32:1533–1539.
Rankin EA, Alarcon GS, Chang RWCooney LM, Costley LS, Delitto A, Deyo RA, Donaldson SK, Hochberg MC, MacLean CH, Yelin EH, Marciel K. NIH consensus statement on total knee replacement, December 8–10, 2003. J Bone Joint Surg Am. 2004;86:1328–1335.
Shah AK, Celestin J, Parks ML, Levy RN. Long-term results of total joint arthroplasty in elderly patients who are frail. Clin Orthop Relat Res. 2004 425:106–109.
Spicer DD, Pomeroy DL, Badenhausen WE, Schaper LA Jr, Curry JI, Suthers KE, Smith MW. Body mass index as a predictor of outcome in total knee replacement. Int Orthop. 2001;25:246–249.
Tierney WM, Fitzgerald JF, Heck DA, Kennedy JM, Katz BP, Melfi CA, Dittus RS, Allen DI, Freund DA. Tricompartmental knee replacement. A comparison of orthopaedic surgeons’ self reported performance rates with surgical indications, contraindications, and expected outcomes. Knee Replacement Patient Outcomes Research Team. Clin Orthop Relat Res. 1994;305:209–217.
Wendelboe AM, Hegmann KT, Biggs JJ, Cox CM, Portmann AJ, Gildea JH, Gren LH, Lyon JL. Relationships between body mass indices and surgical replacements of knee and hip joints. Am J Prev Med. 2003;25:290–295.
Acknowledgments
We thank Jake Drew, MD, and Janel Milner for their contributions and assistance with the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
One or more of the authors (DA) has received funding from Zimmer, Inc.
Each author certifies that his or her institution has approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
Appendices
Appendix 1
Comparison of patient attributes in PORT study, Zimmer total, Zimmer subset with complete data, and single site registry
Pre-TKR Patient attributes | Zimmer subset (Research Cohort)* | Zimmer total | PORT study† | Central NY: Single site |
---|---|---|---|---|
Years of enrollment | 2000–2004 | 2000–2004 | 1992–1993 | 1998–2000 |
# Surgeons | 135 | 171 | 48 | 2 |
# Patients eligible for inclusion | unknown | unknown | 563 | 172 |
# Patients included | 8050 | 17,270 | 291 | 172 |
% Patients included | unknown | unknown | 52 | 100 |
% Patients with followup data* | 100 (1 year) | 51 (1 year) | 92 (2 years) | 100 (1 year) |
Patients Included | ||||
Osteoarthritis diagnosis (%) | 95 | 94 | 100 | 100 |
Knee pain past 6 M (%) | 100 | 100 | 100 | 100 |
Primary TKR (%) | 100 | 100 | 100 | 100 |
Potential Prognostic Variables | ||||
Age (mean years) | 67.8 | 67.6 | 70.2 | 67.3 |
Male % | 34 | 35 | 37 | 34 |
Female % | 66 | 65 | 63 | 66 |
Region of US (# states) | 31 | 36 | Indiana | Central NY |
BMI (mean) | 32 | 32 | 30 | — |
SF12 PCS preoperative | 30.3 | 30.2 | 27.4 | 30.4 |
SF12 MCS preoperative | 52.6 | 53.6 | 52.5 | 52.5 |
KSS- Pain preoperative | 37.0 | 35.6 | 34.7 | — |
KSS- Function preoperative | 47.0 | 47.7 | 41.2 | — |
Outcome Variables | ||||
SF12 PCS 12 month | 43.8 | 42.6 | 38.1 | 40.8 |
Mean PCS change (pre to 12 mo) | 13.6 | 14.1 | 10.5 | 10.4 |
KSS- Pain 6 month | 80.0 | 76.8 | 62.8 | — |
KSS- Function 6 month | 67.3 | 66.1 | 62.5 | — |
Surgeon and hospital factors | ||||
% patients treated by surgeons with annual volume > 20/year | 78% | 73% | 77% | 100% |
Surgeon volume > 20/year in database (%) | 30.4% | 22.5% | — | 100% |
% patients treated in hospitals with annual volume < 50 | 40% | 39% | — | 0 |
Hospital < 50 TKR/year (%) | 41% (n = 92) | 45% (n = 144) | 20% (n = 5) | 0 |
Appendix 2
Mixture Model Detail
The mixture model can be written as: \( y_{i} = {\mathbf{x}}_{i} {\varvec{\upbeta}} + \pi _{1i} e_{1} + \pi _{2i} e_{2} + \varepsilon _{i} \), where \( y_{i} \) is 12-month PCS change of subject \( i \), \( {\mathbf{x}}_{i} \) `is the vector of baseline characteristics of the subject, \( {\varvec{\upbeta}} \) are the coefficients, \( \varepsilon _{i} \sim N\left( {0,\sigma ^{2} } \right) \); \( \pi _{1i} = {{\exp \left( {{\mathbf{z}}_{i} {\varvec{\upalpha}}} \right)} \mathord{\left/ {\vphantom {{\exp \left( {{\mathbf{z}}_{i} {\varvec{\upalpha}}} \right)} {\left( {1 + \exp \left( {{\mathbf{z}}_{i} {\varvec{\upalpha}}} \right)} \right)}}} \right. \kern-\nulldelimiterspace} {\left( {1 + \exp \left( {{\mathbf{z}}_{i} {\varvec{\upalpha}}} \right)} \right)}} \) and \( \pi _{2i} = 1 - \pi _{1i} \) are the mixing probabilities for latent low- and higher-responder groups, \( {\mathbf{z}}_{i} \) is the vector of the \( i \)-th subject’s characteristics that predict his/her probability of belonging to the low responder group, and \( e_{1} \) and \( e_{2} \) are the two discrete random variables corresponding to the low- and high-responder groups. As part of the model, we used a logit function to model the probability of a patient outcome falling in the low functional improvement group (versus high functional gain). A patient was classified into the low functional response group if \( \pi _{1i} > \pi _{2i} \).
About this article
Cite this article
Franklin, P.D., Li, W. & Ayers, D.C. The Chitranjan Ranawat Award. Clin Orthop Relat Res 466, 2597–2604 (2008). https://doi.org/10.1007/s11999-008-0428-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-008-0428-8